You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

delamanid

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)

Recruiting
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Jan 24, 2023

Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +3 more
Jun 22, 2023

Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • HIV
  • Port-au-Prince, Haiti
  • +1 more
Nov 11, 2022

Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • Delamanid
  • +4 more
  • Dasmariñas, Philippines
  • +1 more
Jun 21, 2022

Tuberculosis, HIV Trial in Lima, Cape Town (Bedaquiline, Delamanid, Dolutegravir)

Completed
Has Results
  • Tuberculosis
  • HIV Infections
  • Lima, Peru
  • +2 more
Jan 20, 2022

Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)

Recruiting
  • Pulmonary Tuberculosis
  • Other Specified Pulmonary Tuberculosis
  • Lambaréné, Gabon
  • +7 more
Apr 17, 2023

Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Tuberculosis Infection
  • Denver, Colorado
  • +14 more
Mar 2, 2023

Tuberculosis Trial in Ogre, Siauliai, Vilnius (Delamanid, Optimized Background Regimen (OBR))

Terminated
Has Results
  • Tuberculosis
  • Delamanid
  • Optimized Background Regimen (OBR)
  • Ogre, Latvia
  • +2 more
Oct 14, 2021

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)

Not yet recruiting
  • Pulmonary Tuberculosis
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
  • +37 more
Oct 11, 2023

Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Tbilisi, Georgia
  • +11 more
Feb 14, 2022

Tuberculosis, Multidrug-Resistant Trial in Worldwide (Delamanid, OBR)

Completed
Has Results
  • Tuberculosis, Multidrug-Resistant
  • Beijing, China
  • +7 more
Sep 30, 2021

Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis Trial in Worldwide

Completed
Has Results
  • Tuberculosis, Pulmonary
  • +2 more
  • Delamanid
  • +2 more
  • San Antonio, Texas
  • +16 more
Nov 1, 2021

Antiretroviral Drugs and Related Drugs During and After

Completed
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +61 more
Jun 28, 2022

Tuberculosis, Multidrug-Resistant Trial in Seoul (Linezolid, Delamanid, Levofloxacin)

Unknown status
  • Tuberculosis, Multidrug-Resistant
  • Seoul, Korea, Republic of
    Division of Pulmonology and Critical Care Medicine, Department o
Jan 31, 2019

Tuberculosis Multi Drug Resistant Active Trial (Delamanid, Linezolid, Levofloxacin)

Withdrawn
  • Tuberculosis Multi Drug Resistant Active
  • Delamanid
  • +4 more
  • (no location specified)
Sep 7, 2017